Information:
Fel:
ID
31893
Beskrivning
A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00965653
Länk
https://clinicaltrials.gov/show/NCT00965653
Nyckelord
Versioner (1)
- 2018-10-07 2018-10-07 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
7 oktober 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Rheumatoid Arthritis NCT00965653
Eligibility Rheumatoid Arthritis NCT00965653
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00965653
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Adult | Age
Item
adults 18 - 75 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Rheumatoid Arthritis Duration
Item
active rheumatoid arthritis of >/= 6 months duration
boolean
C0003873 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Methotrexate Response Inadequate | Methotrexate Dose Stable
Item
inadequate response to at least 12 weeks of methotrexate, the last 8 prior to baseline on stable dose
boolean
C0025677 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C0025677 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C0025677 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Swollen joint count | Tender joint count
Item
swollen joint count (sjc)>/=4, tender joint count (tjc)>/=6 at screening and baseline
boolean
C0451521 (UMLS CUI [1])
C0451530 (UMLS CUI [2])
C0451530 (UMLS CUI [2])
DMARDs Discontinued | Anti-TNF drug Discontinued | Exception Methotrexate
Item
dmards and anti-tnfs, other than methotrexate, withdrawn prior to baseline
boolean
C0242708 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1562242 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0025677 (UMLS CUI [3,2])
C1444662 (UMLS CUI [1,2])
C1562242 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0025677 (UMLS CUI [3,2])
Adrenal Cortex Hormones Oral
Item
oral corticosteroids (</= 10mg/day prednisone or equivalent) and nsaids on stable dose </= 4 weeks prior to baseline
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1527415 (UMLS CUI [1,2])
Autoimmune Disease Rheumatic | Exception Rheumatoid Arthritis
Item
rheumatic autoimmune disease other than rheumatoid arthritis
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Inflammatory joint disease | Exception Rheumatoid Arthritis
Item
prior history or current inflammatory joint disease other than rheumatoid arthritis
boolean
C0683381 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Major surgery | Operation on joint | Major surgery Planned
Item
major surgery (including joint surgery) within 8 weeks prior to screening or planned major surgery within 6 months following enrollment
boolean
C0679637 (UMLS CUI [1])
C0185132 (UMLS CUI [2])
C0679637 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
C0185132 (UMLS CUI [2])
C0679637 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
Rheumatoid Arthritis Functional Status Class
Item
functional class iv by acr classification
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])